Alleviation of prolonged postoperative central nervous system depression after treatment with naloxone.
D000769:Anesthesia, Inhalation / Q000009:adverse effects; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects*; D002490:Central Nervous System / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000009:adverse effects / Q000097:blood; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use*; D009609:Nitrous Oxide / Q000009:adverse effects; D013997:Time Factors; D014403:Tubocurarine / Q000009:adverse effects
D000777:Anesthetics; D009270:Naloxone; D009020:Morphine; D009609:Nitrous Oxide; D014403:Tubocurarine